Neuralink Begins Feasibility Trial with Brain Implant and Robotic Arm

Neuralink has initiated a feasibility trial focusing on its innovative brain implant technology and robotic arm. This marks a significant milestone in neural interface advancements, aiming to explore new possibilities for medical and technological applications.

Elon Musk's Neuralink announced on Monday that it has received approval to begin a new feasibility study using its brain implant and a test robotic arm.

Neuralink is conducting its PRIME study to evaluate the safety of its wireless brain-computer interface and surgical robot, focusing on patients with quadriplegia. The trial aims to assess the initial impact of the implant, allowing these patients to control external devices using only their thoughts.

The company intends to include participants from the ongoing PRIME trial in the new feasibility study, according to a post on social media platform X.

Neuralink and the U.S. Food and Drug Administration have not yet responded to requests for further details on the feasibility study.

Just last week, Neuralink received approval from Health Canada to conduct a trial in Canada. In collaboration with Canadian neurosurgeons, the company has been granted approval to recruit six patients with paralysis for the study.

In the U.S., Neuralink has already implanted the device into two patients. The first patient has been able to use it for activities such as playing video games, browsing the internet, posting on social media, and moving a cursor on a laptop.

The company has reported that the second patient is also having success with the device, using it to play video games and design 3D objects.

For questions or comments write to writers@bostonbrandmedia.com

Source: Reuters‍